Atlas Trials

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Clinical trial NCT00006345 · COMPLETED

Trial details

NCT number
NCT00006345
Sponsor
Ligand Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Drug/Agent Toxicity by Tissue/OrganLymphoma
Start date
1999-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.